A Versari Selected Research

Neuroendocrine Tumors (Neuroendocrine Tumor)

1/2012

Radiolabeled somatostatin analogues therapy in advanced neuroendocrine tumors: a single centre experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Versari Research Topics

Disease

3	Neoplasms (Cancer) 01/2018 - 01/2013
3	Vasculitis (Vasculitides) 01/2013 - 01/2007
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Merkel Cell Carcinoma 09/2016
1	Smoldering Multiple Myeloma 02/2016
1	Osteolysis 02/2016
1	Hepatocellular Carcinoma (Hepatoma) 03/2015
1	Prostatic Neoplasms (Prostate Cancer) 03/2015
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2014
1	Hypertension (High Blood Pressure) 01/2013
1	Body Weight (Weight, Body) 01/2013
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2012
1	Arteritis 01/2007
1	Pain (Aches) 03/2005

Drug/Important Bio-Agent (IBA)

6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 01/2007
1	Somatostatin Receptors (Somatostatin Receptor)IBA 09/2016
1	thiamine triphosphorate (TTP)IBA 02/2016
1	Choline (Choline Chloride)IBA 03/2015
1	RadiopharmaceuticalsIBA 03/2015
1	LipidsIBA 03/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2013
1	GlucocorticoidsIBA 01/2013
1	Edotreotide (SMT 487)IBA 01/2013
1	tocilizumab (atlizumab)FDA Link 01/2013
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2012
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2005

Therapy/Procedure

3	Therapeutics 01/2018 - 01/2012
1	Radiotherapy 01/2018
1	Chemoradiotherapy 01/2018
1	Contraindications 01/2013